ALINA GAVRILA, md
330 BROOKLINE AVE · Boston, MA 02215
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
330 BROOKLINE AVE · Boston, MA 02215
732 HARRISON AVENUE, PRESTON, 2ND FLOOR · Boston, MA 02118
732 HARRISON AVE, FL 2, PRESTON BLDG, ENDOCRINOLOGY · Boston, MA 02118
732 HARRISON AVE., PRESTON BLDG., 2ND FL · Boston, MA 02118
221 LONGWOOD AVE FL 2 · Boston, MA 02115
50 STANIFORD ST FL 4 · Boston, MA 02114
15 PARKMAN ST, WAC 730S · Boston, MA 02114
221 LONGWOOD AVE, BRIGHAM AND WOMEN'S HOSPITAL, ENDOCRINOLOGY · Boston, MA 02115
800 WASHINGTON ST · Boston, MA 02111
300 LONGWOOD AVE, DIVISION OF ENDOCRINOLOGY · Boston, MA 02115
732 HARRISON AVE, FL 2, PRESTON BLDG · Boston, MA 02118
15 Parkman St, WAC 730 · Boston, MA 02114
732 HARRISON AVE, 2ND FLOOR · Boston, MA 02118
732 HARRISON AVENUE, PRESTON, 2ND FLOOR · Boston, MA 02118
732 HARRISON AVE, FL 2, PRESTON BLDG · Boston, MA 02118
221 LONGWOOD AVE · Boston, MA 02115
28 Atlantic Avenue · Boston, MA 02110
50 STANIFORD ST FL 3 · Boston, MA 02114
109 STATE ST STE 5 · Boston, MA 02109
4.6(699 Google reviews · 88 in past year)
109 STATE STREET, 5TH FL · Boston, MA 02109
4.6(699 Google reviews · 88 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Boston or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 30 of the 42 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Massachusetts residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.